Skip to main content
Premium Trial:

Request an Annual Quote

Microfluidics-based PSA Diagnostic Device Produces Rapid Results

In MIT's Technology Review, reporter Emily Singer examines new microfluidics technology from the Woburn, Mass.-based Claros Diagnostics, which can detect prostate specific antigen levels in only 15 minutes. "If approved by the US Food and Drug Administration, the device will be one of the first examples of long-awaited microfluidics-based diagnostics tests that can be performed in the hospital or doctor's office," according to Tech Review. The disposable microfluidics cartridge, about the size of a credit card, requires only a small drop of blood; the reader, comparable in size to a toaster, "could, in theory at least, be adapted to detect any number of different proteins," Singer writes. The company is currently running clinical trials — which compare the utility of its device to standard prostate specific antigen testing — and expects results within a few months. Claros hopes to launch their device in Europe later this year and in the US in 2011.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.